Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXOZ3N
|
||||
Drug Name |
3-(3-(1H-imidazol-1-yl)propyl)-1-(4-(methylsulfonyl)benzyl)-5-methyl-5-(naphthalen-1-yl)imidazolidine-2,4-dione
|
||||
Synonyms |
CHEMBL205972
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H28N4O4S
|
||||
Canonical SMILES |
CC1(N(Cc2ccc(cc2)S(=O)(=O)C)C(=O)N(CCCn3ccnc3)C1=O)c4cccc5ccccc45
|
||||
InChI |
InChI=1S/C28H28N4O4S/c1-28(25-10-5-8-22-7-3-4-9-24(22)25)26(33)31(17-6-16-30-18-15-29-20-30)27(34)32(28)19-21-11-13-23(14-12-21)37(2,35)36/h3-5,7-15,18,20H,6,16-17,19H2,1-2H3
|
||||
InChIKey |
ARZMSIQUIDXWHZ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.